US Stock MarketDetailed Quotes

ALX Oncology (ALXO)

Watchlist

2.030
-0.050-2.40%

Close May 12 16:00 ET

2.030
0.0000.00%

Post 16:10 ET

273.16MMarket Cap-1.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology (ALXO) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-40.40%18.97M

-29.21%100.85M

-24.80%23.02M

-30.81%22.53M

-43.47%23.47M

-15.74%31.82M

-16.33%142.47M

-36.25%30.61M

-38.87%32.57M

12.91%41.53M

Selling and administrative expenses

-32.43%5.36M

-8.60%23.85M

-24.08%5.38M

-16.49%5.09M

-20.68%5.45M

31.22%7.93M

-8.39%26.09M

13.50%7.08M

-18.82%6.1M

-5.80%6.87M

-General and administrative expense

-32.43%5.36M

-8.60%23.85M

-24.08%5.38M

-16.49%5.09M

-20.68%5.45M

31.22%7.93M

-8.39%26.09M

13.50%7.08M

-18.82%6.1M

-5.80%6.87M

Research and development costs

-43.04%13.61M

-33.84%77M

-25.02%17.65M

-34.11%17.44M

-47.99%18.02M

-24.68%23.89M

-17.93%116.37M

-43.68%23.53M

-42.16%26.47M

17.54%34.65M

Operating profit

40.40%-18.97M

29.21%-100.85M

24.80%-23.02M

30.81%-22.53M

43.47%-23.47M

15.74%-31.82M

16.33%-142.47M

36.25%-30.61M

38.87%-32.57M

-12.91%-41.53M

Net non-operating interest income expense

-20.98%851K

-69.07%2.36M

-86.91%190K

-78.78%394K

-67.15%701K

-50.93%1.08M

-15.93%7.64M

-43.76%1.45M

-18.77%1.86M

-6.97%2.13M

Non-operating interest income

-20.30%1.18M

-57.68%3.96M

-69.49%573K

-65.18%802K

-56.85%1.11M

-43.44%1.48M

-12.05%9.37M

-37.30%1.88M

-13.97%2.3M

-3.86%2.56M

Non-operating interest expense

-18.47%331K

-7.35%1.6M

-10.30%383K

-8.52%408K

-5.59%405K

-4.92%406K

10.48%1.73M

2.89%427K

14.07%446K

15.32%429K

Other net income (expense)

1,809.09%188K

-15,955.00%-3.21M

-1,600.00%-17K

-300.00%-6K

-39,612.50%-3.18M

21.43%-11K

-105.14%-20K

96.55%-1K

400.00%3K

-102.47%-8K

Special income (charges)

----

---3.18M

--0

---3.18M

----

--0

-Less:Impairment of capital assets

----

--0

--3.18M

----

--0

-Write off

----

--3.18M

--0

--3.18M

----

--0

Other non- operating income (expenses)

1,809.09%188K

-80.00%-36K

-1,600.00%-17K

-300.00%-6K

75.00%-2K

21.43%-11K

-105.14%-20K

96.55%-1K

400.00%3K

-102.47%-8K

Income before tax

41.71%-17.93M

24.59%-101.7M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

16.14%-134.85M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.4M

Income tax

Net income

41.71%-17.93M

24.59%-101.7M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

16.14%-134.85M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.4M

Net income continuous Operations

41.71%-17.93M

24.59%-101.7M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

16.14%-134.85M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.4M

Minority interest income

Net income attributable to the parent company

41.71%-17.93M

24.59%-101.7M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

16.14%-134.85M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.4M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

41.71%-17.93M

24.59%-101.7M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

16.14%-134.85M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.4M

Basic earnings per share

70.69%-0.17

26.36%-1.9

23.64%-0.42

29.31%-0.41

35.53%-0.49

18.31%-0.58

31.02%-2.58

40.22%-0.55

53.23%-0.58

9.52%-0.76

Diluted earnings per share

70.69%-0.17

26.36%-1.9

23.64%-0.42

29.31%-0.41

35.53%-0.49

18.31%-0.58

31.02%-2.58

40.22%-0.55

53.23%-0.58

9.52%-0.76

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-40.40%18.97M	-29.21%100.85M	-24.80%23.02M	-30.81%22.53M	-43.47%23.47M	-15.74%31.82M	-16.33%142.47M	-36.25%30.61M	-38.87%32.57M	12.91%41.53M
Selling and administrative expenses	-32.43%5.36M	-8.60%23.85M	-24.08%5.38M	-16.49%5.09M	-20.68%5.45M	31.22%7.93M	-8.39%26.09M	13.50%7.08M	-18.82%6.1M	-5.80%6.87M
-General and administrative expense	-32.43%5.36M	-8.60%23.85M	-24.08%5.38M	-16.49%5.09M	-20.68%5.45M	31.22%7.93M	-8.39%26.09M	13.50%7.08M	-18.82%6.1M	-5.80%6.87M
Research and development costs	-43.04%13.61M	-33.84%77M	-25.02%17.65M	-34.11%17.44M	-47.99%18.02M	-24.68%23.89M	-17.93%116.37M	-43.68%23.53M	-42.16%26.47M	17.54%34.65M
Operating profit	40.40%-18.97M	29.21%-100.85M	24.80%-23.02M	30.81%-22.53M	43.47%-23.47M	15.74%-31.82M	16.33%-142.47M	36.25%-30.61M	38.87%-32.57M	-12.91%-41.53M
Net non-operating interest income expense	-20.98%851K	-69.07%2.36M	-86.91%190K	-78.78%394K	-67.15%701K	-50.93%1.08M	-15.93%7.64M	-43.76%1.45M	-18.77%1.86M	-6.97%2.13M
Non-operating interest income	-20.30%1.18M	-57.68%3.96M	-69.49%573K	-65.18%802K	-56.85%1.11M	-43.44%1.48M	-12.05%9.37M	-37.30%1.88M	-13.97%2.3M	-3.86%2.56M
Non-operating interest expense	-18.47%331K	-7.35%1.6M	-10.30%383K	-8.52%408K	-5.59%405K	-4.92%406K	10.48%1.73M	2.89%427K	14.07%446K	15.32%429K
Other net income (expense)	1,809.09%188K	-15,955.00%-3.21M	-1,600.00%-17K	-300.00%-6K	-39,612.50%-3.18M	21.43%-11K	-105.14%-20K	96.55%-1K	400.00%3K	-102.47%-8K
Special income (charges)	----	---3.18M	--0	--0	---3.18M	----	--0	--0	--0	--0
-Less:Impairment of capital assets	----	----	----	--0	--3.18M	----	----	----	--0	--0
-Write off	----	--3.18M	--0	--0	--3.18M	----	--0	--0	--0	--0
Other non- operating income (expenses)	1,809.09%188K	-80.00%-36K	-1,600.00%-17K	-300.00%-6K	75.00%-2K	21.43%-11K	-105.14%-20K	96.55%-1K	400.00%3K	-102.47%-8K
Income before tax	41.71%-17.93M	24.59%-101.7M	21.65%-22.85M	27.89%-22.14M	34.14%-25.95M	13.57%-30.75M	16.14%-134.85M	35.87%-29.16M	39.78%-30.71M	-15.34%-39.4M
Income tax		0					0
Net income	41.71%-17.93M	24.59%-101.7M	21.65%-22.85M	27.89%-22.14M	34.14%-25.95M	13.57%-30.75M	16.14%-134.85M	35.87%-29.16M	39.78%-30.71M	-15.34%-39.4M
Net income continuous Operations	41.71%-17.93M	24.59%-101.7M	21.65%-22.85M	27.89%-22.14M	34.14%-25.95M	13.57%-30.75M	16.14%-134.85M	35.87%-29.16M	39.78%-30.71M	-15.34%-39.4M
Minority interest income
Net income attributable to the parent company	41.71%-17.93M	24.59%-101.7M	21.65%-22.85M	27.89%-22.14M	34.14%-25.95M	13.57%-30.75M	16.14%-134.85M	35.87%-29.16M	39.78%-30.71M	-15.34%-39.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	41.71%-17.93M	24.59%-101.7M	21.65%-22.85M	27.89%-22.14M	34.14%-25.95M	13.57%-30.75M	16.14%-134.85M	35.87%-29.16M	39.78%-30.71M	-15.34%-39.4M
Basic earnings per share	70.69%-0.17	26.36%-1.9	23.64%-0.42	29.31%-0.41	35.53%-0.49	18.31%-0.58	31.02%-2.58	40.22%-0.55	53.23%-0.58	9.52%-0.76
Diluted earnings per share	70.69%-0.17	26.36%-1.9	23.64%-0.42	29.31%-0.41	35.53%-0.49	18.31%-0.58	31.02%-2.58	40.22%-0.55	53.23%-0.58	9.52%-0.76
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm